Location History:
- Goodrich, Herefordshire, GB (2009)
- Derby, GB (2014)
- Glasgow, GB (2013 - 2015)
- East Kilbride, GB (2017 - 2023)
- Scotland, GB (2024)
Company Filing History:
6 out of 149 
1 out of 3,540 
2 out of 832,912 Years Active: 2009-2024
Title: John Galloway Anderson: Innovator in Pathogen Inactivation
Introduction
John Galloway Anderson is a notable inventor based in East Kilbride, GB. He has made significant contributions to the field of medical technology, particularly in the area of pathogen inactivation in blood products. With a total of 8 patents to his name, Anderson's work has the potential to enhance the safety of blood transfusions and improve patient outcomes.
Latest Patents
One of Anderson's latest patents focuses on the inactivation of pathogens in ex vivo blood products stored in bags using visible light. This innovative method involves directing visible light radiation from an illuminating device into blood product storage containers. The goal is to achieve effective pathogen inactivation without the need for an added photosensitizing agent. The apparatus includes a control unit that operates a light source emitting light in the wavelength region of about 380-500 nm. This light penetrates the bag material and the opaque blood product to inactivate pathogens while ensuring that the blood product remains undamaged.
Another significant patent addresses the inactivation of medically important Gram-positive bacteria, including Methicillin-resistant Staphylococcus aureus (MRSA) and Coagulase-Negative Staphylococci (CONS). This method also utilizes visible light, specifically light within the wavelength range of 400-500 nm, to effectively inactivate these harmful bacteria.
Career Highlights
Throughout his career, John Galloway Anderson has worked with esteemed institutions, including the University of Strathclyde. His research and innovations have garnered attention in the medical community, contributing to advancements in blood safety and pathogen control.
Collaborations
Anderson has collaborated with notable colleagues such as Michelle Maclean and Scott John MacGregor. Their combined expertise has furthered the development of innovative solutions in the field of medical technology.
Conclusion
John Galloway Anderson's contributions to pathogen inactivation in blood products represent a significant advancement in medical technology. His innovative methods and dedication to improving blood safety have the potential to save lives and enhance patient care.